Clinical Significance of Protein Expression of Cyclooxygenase-2 and Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Tumors

10.1016/j.bpg.2005.06.002

10.1159/000085237

10.1111/j.1440-1827.1997.tb03723.x

10.1002/ijc.11446

10.1159/000107555

10.1046/j.1440-1827.2001.01273.x

10.1385/EP:15:4:275

10.1093/annonc/10.suppl_2.S31

10.1200/JCO.2008.21.5988

10.1677/erc.1.01200

Greene, 2002,

Solcia, 2000, , 38

10.1007/s10549-005-9062-2

10.1007/s00535-009-0194-8

Okami, 2002, An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas, 569

10.1007/BF02976879

10.1002/ijc.20256

10.1111/j.1745-7254.2007.00652.x

10.1200/JCO.2009.22.8510

10.1016/j.tem.2004.07.002

Buscail, 1996, Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer, 1823

10.1089/cbr.2009.0708

10.1159/000322040

Papotti, 2002, Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis, 461